Ranitidine ban deferred despite cancer concerns
Live Events
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
New Delhi: Despite concerns over presence of cancer causing agents in popular antacid Ranitidine and a recent recommendation by an expert panel for suspension of the drug, India's top drug advisory body has decided to ignore and form another "larger committee" to look into all aspects of the drug.It is widely sold in India under brand names like Aciloc, Rantac and Zinetac.After a meeting held last week, the Drugs Technical Advisory Body (DTAB) also recommended that the Indian Council of Medical Research (ICMR) should conduct a study to assess the safety of the drug. The drug was withdrawn/suspended by regulatory bodies including the USFDA, European Medicines Agency (EMA), and Australia among others,Last year a committee was constituted to examine the safety issue of Ranitidine in the light of the nitrosodimethylamine (NDMA) impurity.The experts got samples of Ranitidine tested at a government run laboratory. Of the 42 Ranitidine samples tested at the Central Drug Laboratory in Kolkata, 21 were found to contain NDMA impurities exceeding 0.32 PPM. This level surpasses the globally acceptable limit for the impurity, which is linked to an increased risk of cancer over a lifetime.After evaluating the global regulatory status of the drug and having found some of the samples in India exceeding the safety limit, the expert committee recommended for the "suspension of the drug Ranitidine for manufacture, sale and distribution in the country," it said. The committee also recommended that the people taking Ranitidine should consult their health care professional for other treatment options.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
11 hours ago
- Economic Times
27-year-old Mumbai woman's heart attack case reveals how PCOS, contraceptive pills may be putting young women at serious risk
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel While many Mumbaikars dread April for its scorching heat, 27-year-old Payal (name changed), a resident of Mahim, looked back on the month with happy memories as a newlywed. But on June 2, her life took a frightening turn when she suffered a heart attack after a day of severe acidity and sharp chest pain late at night.'She showed ECG changes at 2 am that confirmed a heart attack,' said cardiologist Dr Kaushal Chhatrapati of Saifee Hospital near Charni Road. He added that he placed a stent in her circumflex artery early on June 3 to restore blood heart attack came as a shock to Payal's family, especially since she is young and women of childbearing age are generally protected against heart disease by the hormone estrogen. Estrogen helps keep blood vessels open and reduces to a TOI report quoting Dr Chhatrapati, the likely cause in Payal's case was the contraceptive pills she had been taking for polycystic ovary syndrome (PCOS), a hormonal disorder causing irregular periods and ovarian cysts. Payal's father said she had battled PCOS for nearly ten years and had been on contraceptive pills for seven years.A study from Denmark published in the medical journal The BMJ in February found that the commonly used combined estrogen-progestin contraceptive pill doubled the risk of ischemic stroke and heart attack. The study estimated that for every 4,760 women using the pill for one year, there would be one extra stroke, and for every 10,000 women per year, one extra heart attack. Estrogen-containing products like vaginal rings and skin patches were particularly noted as per the TOI report, gynaecologist Dr Kiran Coelho said strokes were more common than heart attacks linked to contraceptive pills. 'I have seen women as young as 22 and 28 with PCOS suffering strokes. But many women need these pills to suppress ovulation, which reduces cyst formation in the ovaries,' she often comes with obesity and insulin resistance, which can cause dyslipidaemia, high levels of fats in the blood that increase the risk of heart disease. 'Urban women face high stress levels, and childhood obesity is rising. These factors raise the chances of PCOS, which affects one in every five adolescent girls in urban India,' Dr Coelho Rajeev Bhagwat, cardiologist at Nanavati Hospital in Vile Parle, pointed out that while contraceptive pills are known to increase the risk of blood clots, doctors should carefully review a woman's family history of heart disease before prescribing them. 'Family history is a very strong factor for heart disease in young people,' he from TOI
Time of India
11 hours ago
- Time of India
27-year-old Mumbai woman's heart attack case reveals how PCOS, contraceptive pills may be putting young women at serious risk
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel While many Mumbaikars dread April for its scorching heat, 27-year-old Payal (name changed), a resident of Mahim, looked back on the month with happy memories as a newlywed. But on June 2, her life took a frightening turn when she suffered a heart attack after a day of severe acidity and sharp chest pain late at night.'She showed ECG changes at 2 am that confirmed a heart attack,' said cardiologist Dr Kaushal Chhatrapati of Saifee Hospital near Charni Road. He added that he placed a stent in her circumflex artery early on June 3 to restore blood heart attack came as a shock to Payal's family, especially since she is young and women of childbearing age are generally protected against heart disease by the hormone estrogen. Estrogen helps keep blood vessels open and reduces to a TOI report quoting Dr Chhatrapati, the likely cause in Payal's case was the contraceptive pills she had been taking for polycystic ovary syndrome (PCOS), a hormonal disorder causing irregular periods and ovarian cysts. Payal's father said she had battled PCOS for nearly ten years and had been on contraceptive pills for seven years.A study from Denmark published in the medical journal The BMJ in February found that the commonly used combined estrogen-progestin contraceptive pill doubled the risk of ischemic stroke and heart attack. The study estimated that for every 4,760 women using the pill for one year, there would be one extra stroke, and for every 10,000 women per year, one extra heart attack. Estrogen-containing products like vaginal rings and skin patches were particularly noted as per the TOI report, gynaecologist Dr Kiran Coelho said strokes were more common than heart attacks linked to contraceptive pills. 'I have seen women as young as 22 and 28 with PCOS suffering strokes. But many women need these pills to suppress ovulation, which reduces cyst formation in the ovaries,' she often comes with obesity and insulin resistance, which can cause dyslipidaemia, high levels of fats in the blood that increase the risk of heart disease. 'Urban women face high stress levels, and childhood obesity is rising. These factors raise the chances of PCOS, which affects one in every five adolescent girls in urban India,' Dr Coelho Rajeev Bhagwat, cardiologist at Nanavati Hospital in Vile Parle, pointed out that while contraceptive pills are known to increase the risk of blood clots, doctors should carefully review a woman's family history of heart disease before prescribing them. 'Family history is a very strong factor for heart disease in young people,' he from TOI
Time of India
12 hours ago
- Time of India
6,000+ active Covid cases in India again! With over 800 new infections in 48 hours, experts raise alarm
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel India has recorded over 6,000 active Covid cases , with 769 new infections reported in the last 48 hours, according to data from the Union Health Ministry released on remains the worst-affected state, followed by Gujarat, West Bengal and Delhi. The rise in cases has prompted the Centre to conduct mock drills at hospitals to check preparedness. States have been asked to ensure the availability of oxygen, ventilators, isolation beds, and essential medicines, official sources of now, India has 6,133 active Covid cases. In the last 24 hours, six more deaths were reported. However, most of the current cases are mild and being treated at home, the ministry January 2025, a total of 65 deaths related to Covid have been recorded in the country. Just two weeks ago, on May 22, there were only 257 active review the situation and preparedness measures, a series of technical meetings were held on June 2 and 3, chaired by Dr Sunita Sharma, Director General of Health Services. These meetings included representatives from the Disaster Management Cell, Indian Council of Medical Research (ICMR), National Centre for Disease Control, central hospitals in Delhi, and all states and Union June 4, sources said that state and district surveillance teams are monitoring cases of Influenza-Like Illness (ILI) and Severe Acute Respiratory Illness (SARI). As per the guidelines, all admitted SARI patients should be tested, and 5% of ILI cases are also being checked. Positive samples are sent for genome sequencing through the ICMR from PTI
